Iovance Biotherapeutics IOVA
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 2.73 | 102.43 | -0.15 | -73,460 | -72 | |
| 2025Q3 | 2.17 | 101.33 | -0.25 | -94,901 | -91 | |
| 2025Q2 | 1.72 | 103.74 | -0.33 | -113,774 | -112 | |
| 2025Q1 | 3.33 | 102.73 | -0.36 | -121,221 | -116 | |
| 2024Q4 | 7.40 | 112.43 | -0.25 | -86,576 | -79 | |
| 2024Q3 | 9.39 | 104.71 | -0.27 | -89,066 | -84 | |
| 2024Q2 | 8.02 | 103.40 | -0.34 | -101,914 | -97 | |
| 2024Q1 | 14.82 | 102.92 | -0.42 | -117,722 | -113 | |
| 2023Q4 | 8.13 | 102.64 | -0.45 | -121,256 | -116 | |
| 2023Q3 | 4.55 | 102.92 | -0.46 | -118,361 | -114 | |
| 2023Q2 | 7.04 | 102.88 | -0.48 | -110,086 | -107 | |
| 2023Q1 | 6.11 | 103.25 | -0.50 | -110,856 | -107 | |
| 2022Q4 | 6.39 | 101.63 | -0.64 | -107,036 | -105 | |
| 2022Q3 | 9.58 | 100.78 | -0.64 | -100,395 | -100 | |
| 2022Q2 | 11.04 | 100.39 | -0.63 | -99,734 | -99 | |
| 2022Q1 | 16.65 | 100.12 | -0.58 | -91,713 | -92 | |
| 2021Q4 | 19.09 | 100.14 | -0.63 | -99,465 | -99 | |
| 2021Q3 | 24.66 | 100.14 | -0.56 | -86,242 | -86 | |
| 2021Q2 | 26.02 | 100.09 | -0.53 | -81,426 | -81 | |
| 2021Q1 | 31.66 | 100.16 | -0.51 | -75,570 | -75 |